Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10965633 | Vaccine | 2014 | 6 Pages |
Abstract
Both formulations were immunogenic in this population but required more vaccinations to reach seroprotective levels than comparable regimens in healthy individuals, as expected. The relatively reduced SPRs seen in this population support the need for routine screening and re-dosing in this population.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Christopher L. Gilbert, Jon E. Stek, Giuseppe Villa, Stephanie O. Klopfer, Jason C. Martin, Florian P. Schödel, Prakash K. Bhuyan,